Olwen Hahn to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Olwen Hahn has written about Antimetabolites, Antineoplastic.
Connection Strength
0.344
-
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer. J Oncol Pharm Pract. 2026 Jan; 32(1):62-70.
Score: 0.198
-
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
Score: 0.146